Haleos Labs Limited vs Vivanza Biosciences Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Jun 15, 2026

Key Highlights

The Latest Trading Price of Haleos Labs Limited is ₹ 1356 as of 12 Jun 15:30 . The P/E Ratio of Haleos Labs Limited changed from 11 on March 2021 to 16.2 on March 2025 . This represents a CAGR of 8.05% over 5 yearsThe P/E Ratio of Vivanza Biosciences Ltd changed from 687.4 on March 2021 to 0 on March 2025 . This represents a CAGR of -100.00% over 5 years The Market Cap of Haleos Labs Limited changed from ₹ 149.61 crore on March 2021 to ₹ 326.64 crore on March 2025 . This represents a CAGR of 16.90% over 5 yearsThe Market Cap of Vivanza Biosciences Ltd changed from ₹ 52.24 crore on March 2021 to ₹ 7.96 crore on March 2025 . This represents a CAGR of -31.36% over 5 years The revenue of Haleos Labs Limited for the Mar '26 is ₹ 77.15 crore as compare to the Dec '25 revenue of ₹ 94.97 crore. This represent the decline of -18.76% The revenue of Vivanza Biosciences Ltd for the Mar '26 is ₹ 6.37 crore as compare to the Dec '25 revenue of ₹ 45.33 crore. This represent the decline of -85.95% The ebitda of Haleos Labs Limited for the Mar '26 is ₹ 6.17 crore as compare to the Dec '25 ebitda of ₹ 14.23 crore. This represent the decline of -56.64% The ebitda of Vivanza Biosciences Ltd for the Mar '26 is ₹ -0.22 crore as compare to the Dec '25 ebitda of ₹ 0.29 crore. This represent the decline of -175% The net profit of Haleos Labs Limited changed from ₹ 7.1 crore to ₹ 0.34 crore over 8 quarters. This represents a CAGR of -78.12% The net profit of Vivanza Biosciences Ltd changed from ₹ 0.27 crore to ₹ -0.45 crore over 8 quarters. This represents a CAGR of NaN% The Dividend Payout of Haleos Labs Limited changed from 3.44 % on March 2021 to 2.12 % on March 2025 . This represents a CAGR of -9.23% over 5 yearsThe Dividend Payout of Vivanza Biosciences Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Haleos Labs Limited

SMS Lifesciences India Limited was incorporated originally as 'Potluri Real Estate Private Limited' on May 31, 2006.
The Company's name was changed to 'Potluri Packaging Industries Private Limited' on 6 November, 2013 and again changed to 'SMS Lifesciences India Private Limited on 4 August, 2014 to undertake the activities related pharma sector.
The Company became a wholly owned subsidiary Company of SMS Pharmaceuticals Limited w.e.f. 01.04.2016 and subsequently got converted into a Public Limited w.e.f. 22 June, 2016. The Company is engaged in the business of manufacturing and export of Active Pharma Ingredients(APIs) and their intermediates.
The Company is having manufacturing facilities at Kazipally and Jeedimetla, Hyderabad with an installed capacity of 65 KL. What started off as a single facility - single product manufacturing company in 1990 grew to be a multi-location group having products spread across an array of therapeutic segments.

About Vivanza Biosciences Ltd

Vivanza Biosciences Limited, formerly known as Ivee Injectaa Limited was established in March, 1982 as a Private Limited Company and was converted into a Public Limited Company in May, 1992.
Due to recessionary trends which lead to difficult business conditions in year 1999-2000, the parenteral industry suffered a setback and due to this, the name of the Company was changed from Ivee Injectaa Limited to Vivanza Biosciences Limited in 2015. The Company is focused in commercializing novel and generic pharmaceuticals, offering patients better, safe and more accessible medicines.
It is presently engaged in the business of Pharmaceutical Products. Head quartered in Gujarat, India, Company came into existence in April 2016 to further spread its wings in global market with global quality pharmaceutical products at competitive pricing system.

FAQs for the comparison of Haleos Labs Limited and Vivanza Biosciences Ltd

Which company has a larger market capitalization, Haleos Labs Limited or Vivanza Biosciences Ltd?

Market cap of Haleos Labs Limited is 409 Cr while Market cap of Vivanza Biosciences Ltd is 6 Cr

What are the key factors driving the stock performance of Haleos Labs Limited and Vivanza Biosciences Ltd?

The stock performance of Haleos Labs Limited and Vivanza Biosciences Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Haleos Labs Limited and Vivanza Biosciences Ltd?

As of June 15, 2026, the Haleos Labs Limited stock price is INR ₹1356.0. On the other hand, Vivanza Biosciences Ltd stock price is INR ₹1.7.

How do dividend payouts of Haleos Labs Limited and Vivanza Biosciences Ltd compare?

To compare the dividend payouts of Haleos Labs Limited and Vivanza Biosciences Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.